Traynor Capital Management, Inc. Pfizer Inc Transaction History

Traynor Capital Management, Inc.

$1.6 Billion
Q3 2024

A detailed history of Traynor Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Traynor Capital Management, Inc. holds 27,328 shares of PFE stock, worth $750,426. This represents 0.05% of its overall portfolio holdings.

Number of Shares

27,328

Previous 78,500 65.19%

Holding current value

$750,426

Previous $2.2 Million 64.03%

% of portfolio

0.05%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $40,026 - $45,358	1,445 Added 5.58%	27,328 $790,000
Q2 2024 Jul 24, 2024	BUY	$25.26 - $29.6 $103,667 - $121,478	4,104 Added 18.84%	25,883 $724,000
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $1,527 - $1,754	59 Added 0.27%	21,779 $604,000
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $310,764 - $403,648	-11,893 Reduced 35.38%	21,720 $625,000
Q3 2023 Oct 16, 2023	BUY	$32.09 - $37.51 $77,689 - $90,811	2,421 Added 7.76%	33,613 $1.11 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $83,545 - $96,660	-2,313 Reduced 6.9%	31,192 $1.14 Million
Q1 2023 Apr 21, 2023	BUY	$39.39 - $51.28 $185,881 - $241,990	4,719 Added 16.39%	33,505 $1.37 Million
Q4 2022 Jan 27, 2023	SELL	$41.75 - $54.5 $39,746 - $51,884	-952 Reduced 3.2%	28,786 $0
Q3 2022 Nov 15, 2022	SELL	$43.76 - $53.42 $766,894 - $936,185	-17,525 Reduced 37.08%	29,738 $1.3 Million
Q3 2022 Oct 20, 2022	BUY	$43.76 - $53.42 $813,235 - $992,757	18,584 Added 64.8%	47,263 $2.07 Million
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $4,839 - $5,737	104 Added 0.36%	28,679 $1.5 Million
Q1 2022 Apr 13, 2022	SELL	$45.75 - $56.69 $4.29 Million - $5.31 Million	-93,676 Reduced 76.63%	28,575 $1.48 Million
Q4 2021 Feb 01, 2022	BUY	$41.32 - $61.25 $240,399 - $356,352	5,818 Added 5.0%	122,251 $7.22 Million
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $13,619 - $17,495	-347 Reduced 0.3%	116,433 $5.01 Million
Q2 2021 Jul 21, 2021	SELL	$35.91 - $40.68 $92,683 - $104,995	-2,581 Reduced 2.16%	116,780 $4.64 Million
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $57,100 - $64,397	-1,705 Reduced 1.41%	119,361 $4.32 Million
Q4 2020 Jan 14, 2021	BUY	$33.47 - $42.56 $1.09 Million - $1.39 Million	32,587 Added 36.83%	121,066 $4.46 Million
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $530,828 - $622,782	16,719 Added 23.3%	88,479 $3.38 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $650,411 - $789,044	21,594 Added 43.05%	71,760 $2.35 Million
Q1 2020 Apr 29, 2020	BUY	$27.03 - $38.62 $317,413 - $453,514	11,743 Added 30.56%	50,166 $1.64 Million
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $127,499 - $144,695	3,873 Added 11.21%	38,423 $1.51 Million
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $126,873 - $164,517	3,905 Added 12.74%	34,550 $1.24 Million
Q2 2019 Jul 26, 2019	BUY	$36.98 - $41.52 $17,676 - $19,846	478 Added 1.58%	30,645 $1.34 Million
Q1 2019 Apr 12, 2019	BUY	$37.5 - $41.2 $57,150 - $62,788	1,524 Added 5.32%	30,167 $1.28 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $48,856 - $55,702	-1,270 Reduced 4.25%	28,643 $1.25 Million
Q3 2018 Oct 24, 2018	SELL	$34.47 - $41.81 $19,647 - $23,831	-570 Reduced 1.87%	29,913 $1.32 Million
Q2 2018 Aug 03, 2018	SELL	$32.98 - $35.16 $65,069 - $69,370	-1,973 Reduced 6.08%	30,483 $1.11 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $48,662 - $56,455	1,525 Added 4.93%	32,456 $1.15 Million
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $5,820 - $6,175	-175 Reduced 0.56%	30,931 $1.12 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $964,286 - $1.06 Million	31,106	31,106 $1.11 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Traynor Capital Management, Inc. with notifications on news.

Account

Traynor Capital Management, Inc. Pfizer Inc Transaction History